Tesalys in the news

Tesalys invented machines to treat infectious waste on-site, offering an eco-friendly alternative to incineration, and is expanding internationally after seeing increased demand during the pandemic.

Tesalys is urging the French government to adopt its on-site medical waste shredding and decontamination systems to handle the surge in infectious materials from hospitals.

Tesalys is exporting its shredder-sterilizer machines to China for on-site treatment of infectious medical waste, including a specialized pre-program for coronavirus.

Tesalys is shipping dozens of on-site medical waste decontamination machines to China to help hospitals treat infectious COVID-19 waste locally.

Tesalys manufactures the St riplus machine, which disinfects and shreds infectious waste, with over 200 units sold globally.

French SMEs Valmy, Kolmi-Hopen, and Tesalys are experiencing a surge in orders for masks and infectious waste treatment machines due to the global coronavirus outbreak, leading to increased production and hiring.

Tesalys invested 1 million euros in a new industrial building to increase its production capacity for sterilization machines and plans to enter the North American market in 2020.

Tesalys, a Toulouse-based manufacturer of medical waste treatment machines, raised 6 million euros to expand its assembly capabilities, strengthen international presence, and increase sales.

Tesalys raised 1.5 million euros to develop advanced hospital waste shredding and sterilization machines, expanding its global market presence and contributing to humanitarian efforts.

Tesalys developed Steriplus, a machine that shreds and disinfects infectious medical waste, turning it into safe, disposable confetti.

Tesalys aims to triple its 2M System will provide summary in English regardless of input language.

Tesalys manufactures on-site infectious waste shredding and sterilization machines and is rapidly expanding its international export presence.

Tesalys developed a compact machine that treats infectious medical waste on-site by sterilizing and shredding it, turning it into ordinary waste for household disposal, and is now expanding its market in France after international success.

Tesalys raised one million euros from Entrepreneur Venture to expand its on-site infectious waste treatment solutions.

Tesalys raised 1 million euros to scale production and global sales of its integrated medical waste shredding and sterilization equipment.

Tesalys, a provider of infectious waste treatment solutions, finalized its first funding round, securing 1 million from Entrepreneur Venture to fuel international expansion and industrialization.

Tesalys is set to launch and export its innovative, compact, and autonomous on-site systems for treating infectious biological waste, combining shredding and disinfection.